Pet Nutrition Market: Fresh Food Subscription and Therapeutic Diet Premiumisation to Drive Market Growth

The global pet nutrition market was valued at USD 138.4 billion in 2025 and is projected to reach USD 235.82 billion by 2035, expanding at a CAGR of 6.1%. Pet nutrition is the largest consumer-facing animal health market segment, encompassing dry kibble, wet food, freeze-dried raw, fresh refrigerated meals, veterinary therapeutic diets, and pet treats for dogs, cats, and other companion animals. The market is driven by pet humanisation elevating food quality expectations, the premiumisation shift toward grain-free, high-protein, and species-appropriate formulations, and the direct-to-consumer fresh pet food subscription model creating a new premium segment.

Veterinary therapeutic diets — Hill’s Prescription Diet (Colgate-Palmolive), Royal Canin Veterinary Diet (Mars), and Purina Pro Plan Veterinary Diet (Nestlé) — represent the highest-margin and most clinically differentiated segment, prescribed by veterinarians for weight management, kidney disease, urinary health, dermatology, and gastrointestinal conditions. Fresh refrigerated pet food (Freshpet, The Farmer’s Dog, Ollie) is the fastest-growing format, growing at above-20% annually from consumer willingness to pay for minimally processed human-grade pet food delivered directly to home.

Executive Snapshot

What is the confirmed market size and growth trajectory for the pet nutrition market?
The market was valued at USD 138.4 billion in 2025 and is projected to grow at a CAGR of 6.1% to USD 235.82 billion by 2035. Dry food is the dominant format by volume. Wet food is the fastest-growing conventional format. Fresh/refrigerated food is the fastest-growing premium segment. Dogs are the dominant species by spend. North America and Europe lead; Asia-Pacific grows fastest from pet ownership expansion.

What is the commercial model of veterinary therapeutic diets and why do they command premium pricing?
Veterinary therapeutic diets are sold exclusively through veterinary practices or by veterinary prescription — positioning them as prescription analogous, premium-priced products that command two to three times the average premium pet food price. Clinical efficacy data, prescription-only distribution, and the veterinary endorsement model create a defensible premium that generic pet food manufacturers cannot replicate, sustaining Hill’s, Royal Canin, and Purina Pro Plan Veterinary Diet margins above general premium pet food brands.

How does the fresh pet food subscription model create a structurally distinct market segment?
Direct-to-consumer fresh pet food subscriptions — where human-grade, minimally processed meals are portioned per-animal and delivered weekly — command USD 50 to USD 200 monthly per pet, representing 3x to 10x the per-meal cost of conventional premium dry kibble. The subscription model creates recurring revenue, high retention through personalised meal planning, and emotional brand connection through the premium fresh food experience — creating a capital-efficient growth model that conventional pet food manufacturers’ retail channel economics cannot replicate.

How does the companion animal pharmaceutical market integrate with pet nutrition?
Zoetis’s companion animal portfolio — serving dogs, cats, and horses across dermatology, parasiticides, and pain management — creates natural clinical co-management with therapeutic nutrition. A dog with atopic dermatitis managed with Apoquel may simultaneously receive Hill’s Derm Defense diet; a cat with chronic kidney disease managed with Elanco’s renal products may receive Royal Canin Renal diet — creating integrated pharmaceutical-nutritional management protocols that sustain both market segments.

How does IDEXX cancer screening affect pet nutrition decisions?
IDEXX Cancer Dx Panel detection of companion animal lymphoma triggers oncology specialist consultation that routinely includes nutritional assessment and therapeutic diet recommendation — with high-quality nutrition recognised as a component of cancer supportive care that sustains pet nutrition demand from the growing companion animal oncology patient population receiving chemotherapy or palliative management.

What is driving the insect protein and alternative ingredient pet food segment?
Insect protein (black soldier fly larvae), lab-grown meat, and plant-based pet food alternatives are growing from consumer sustainability awareness — with pet owners increasingly considering the environmental footprint of companion animal protein consumption. This sustainability-driven innovation is creating new premium pet nutrition sub-segments above conventional animal protein-based formulations.

Market Dynamics: Pet Nutrition Market

  • Fresh refrigerated pet food growing above 20% annually from direct-to-consumer subscription model adoption. The Farmer’s Dog, Ollie, Freshpet and similar fresh pet food brands growing at above-20% from consumer premium fresh food preferences extending to companion animal nutrition.
  • Veterinary therapeutic diet prescribed for chronic disease management sustaining premium recurring revenue. Veterinary prescription for Hill’s, Royal Canin, and Purina Pro Plan Veterinary diets for renal disease, diabetes, and obesity creating 2-3x premium pricing with high adherence from veterinary recommendation.
  • Pet food personalization — ingredient, breed, life stage customization — growing as DTC brands enable mass customization. DTC pet nutrition brands offering breed-specific, age-specific, and health-condition-specific meal customization that mass-market kibble cannot deliver — sustaining premium pricing from personalization value.
  • Sustainability-positioned insect protein and alternative ingredient pet food segment emerging as premium eco-conscious category. Consumer environmental consciousness extending to companion animal food sustainability — insect protein and plant-based pet food alternatives growing as a premium sustainability segment.
  • Asia-Pacific pet food market growing fastest from first-generation urban pet owner premium product adoption. China and Southeast Asia first-generation urban pet owners adopting premium pet nutrition — including imported premium brands and domestic fresh food equivalents — at above-global growth rates.
  • Pet food regulatory harmonization creating trade opportunity for premium brand geographic expansion. International pet food regulatory alignment enabling premium brand export from North America and Europe to emerging Asian markets — creating geographic expansion opportunity for established premium brands.

Market Segmentation: Pet Nutrition Market

By Pet Type
  • Dogs
  • Cats
  • Fish
  • Birds
  • Small Mammals
  • Reptiles
  • Horses
  • Other Pets
By Product Type
  • Dry Food
  • Wet Food
  • Treats & Snacks
  • Supplements
  • Vitamins & Minerals
  • Functional Foods
  • Milk Replacers
  • Veterinary Diets (Prescription Food)
  • Freeze-Dried & Raw Food
  • Other Pet Nutrition Products
By Ingredient Type
  • Meat-Based
  • Plant-Based
  • Grain-Free
  • Organic
  • Hypoallergenic
  • Insect Protein-Based
  • Novel Protein-Based
  • Natural Ingredients
  • Functional Ingredients
  • Other Ingredient Types
By Health Benefit
  • Digestive Health
  • Joint & Bone Health
  • Skin & Coat Health
  • Weight Management
  • Dental Health
  • Immune Health
  • Urinary Health
  • Heart Health
  • Cognitive Health
  • Allergy & Sensitivity Management
  • Other Health Benefits
By Form
  • Kibble
  • Canned
  • Semi-Moist
  • Freeze-Dried
  • Dehydrated
  • Raw
  • Powder
  • Liquid
  • Chews
  • Others
By Distribution Channel
  • Mass Merchandisers
  • Pet Specialty Stores
  • Online Retailers
  • Veterinary Clinics & Hospitals
  • Grooming Salons
  • Supermarkets & Hypermarkets
  • Convenience Stores
  • Brand-Owned Stores
By Price Range
  • Economy
  • Mid-Range
  • Premium
  • Super Premium
  • Ultra-Premium
By End User
  • Household Pet Owners
  • Breeders
  • Veterinary Clinics & Hospitals
  • Animal Shelters & Rescue Organizations
  • Pet Boarding & Daycare Centers
  • Pet Grooming Centers
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Pet Nutrition Market

  1. Veterinary therapeutic diet prescription model sustaining 2-3x premium pricing with clinical efficacy differentiation. Veterinary prescription model for therapeutic diets creating price-protected premium channel sustaining Hill’s, Royal Canin, and Purina Pro Plan Vet Diet margin leadership.
  2. Pet humanisation creating structurally non-discretionary companion animal healthcare spending. Pet humanisation elevating companion animal healthcare to human medicine equivalence creates non-discretionary spending growing with pet ownership and income.
  3. One Health framework sustaining public investment in animal health independent of commercial cycles. One Health policy creating government funding for zoonotic surveillance, AMR stewardship, and food safety that supports animal health market growth.
  4. Global protein demand from emerging market growth driving farm animal production intensification. Emerging market protein consumption growth requiring food animal production intensification creating proportionate veterinary health product demand.
  5. Companion animal mAb therapeutics creating recurring monthly revenue above single-purchase pharmaceutical cycles. Monthly-dosed mAb therapeutics (Cytopoint, Librela, Solensia) generating recurring clinical revenue that compounds market growth above conventional product replacement.
  6. Asia-Pacific simultaneous pet ownership expansion and livestock intensification creating fastest-growing regional demand. Asia-Pacific growing fastest from dual companion animal and livestock market development driven by economic growth and urbanisation.

Regional Outlook: Pet Nutrition Market

  • North America: Dominant established market anchored by Zoetis’s approximately USD 9.5 billion 2025 revenue, IDEXX’s approximately 80-laboratory diagnostic network, and the world’s highest companion animal per-animal healthcare spending — driving product innovation adoption faster than any other regional market.
  • Europe: Significant established market where Boehringer Ingelheim Animal Health and Virbac operate under EU 2019/6 antimicrobial stewardship regulation — the world’s most stringent livestock antibiotic framework — driving vaccine and alternative product adoption across farm animal health.
  • Asia-Pacific: Fastest-growing regional market driven by China’s pet ownership boom, India’s livestock production intensification, and Southeast Asia’s growing veterinary care adoption. The region holds 60-plus percent of global livestock populations creating structural farm animal health demand growing proportionately with protein consumption.

Competitive Landscape: Pet Nutrition Market

Key Players: Zoetis Inc. (NYSE: ZTS), Elanco Animal Health (NYSE: ELAN), Boehringer Ingelheim Animal Health, Merck Animal Health, IDEXX Laboratories (NASDAQ: IDXX), Virbac, Vétoquinol, Ceva Santé Animale, Antech Diagnostics (Mars), Dechra Pharmaceuticals, Phibro Animal Health, and Norbrook Laboratories

Recent Developments

  • Zoetis’ FY2024 Annual Report filed with the SEC confirmed Zoetis’s companion animal focus serving dogs, cats and horses — establishing the companion animal health platform that therapeutic pet nutrition complements through veterinary co-management of conditions including dermatology, renal disease, obesity, and gastrointestinal disorders where pharmaceutical and nutritional management work in clinical combination.
  • Elanco Animal Health’s FY2025 Annual Report filed with the SEC confirmed Elanco’s pet health portfolio for dogs and cats — including therapeutics for conditions where veterinary therapeutic diet co-management is clinically indicated — reflecting the integrated clinical approach to companion animal health where pharmaceutical and nutritional management are prescribed together for conditions including inflammatory bowel disease, chronic kidney disease, and obesity.
  • IDEXX Laboratories’ FY2025 Annual Report filed with the SEC confirmed IDEXX’s cancer screening and therapy management services — including nutritional assessment as a component of companion animal oncology care — with IDEXX Cancer Dx Panel detection triggering oncology care pathways that routinely incorporate high-quality nutritional support as part of cancer patient management.

Consultant POV

The Pet Nutrition Market’s 6.1% CAGR through 2035 from USD 138.4 billion in 2025 is structurally anchored in the most durable growth drivers in the life sciences sector — pet humanisation, food security investment, and One Health policy — each of which grows independently of economic cycles. Zoetis’s USD 9.5 billion 2025 revenue and 12 blockbuster-potential pipeline candidates, Elanco’s 90-plus country global footprint, and IDEXX’s continuous diagnostic innovation confirm that the pet nutrition market’s 6.1% CAGR from USD 138.4 billion in 2025 reflects the largest consumer-facing animal health market sustaining steady growth from pet humanisation premiumisation — with the fresh food subscription segment’s above-20% growth and veterinary therapeutic diet premiumisation collectively sustaining market value creation above the conventional pet food replacement cycle.

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

Speak with an Analyst

    Download TOC